Effects of piposulfan (Ancyte) on protein and DNA synthesis in Ehrlich ascites carcinoma.
D000477:Alkylating Agents / Q000627:therapeutic use*; D000818:Animals; D002247:Carbon Isotopes; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy* / Q000378:metabolism; D002452:Cell Count; D002470:Cell Survival; D004273:DNA, Neoplasm / Q000096:biosynthesis*; D007930:Leucine / Q000378:metabolism; D008297:Male; D051379:Mice; D009363:Neoplasm Proteins / Q000096:biosynthesis*; D009368:Neoplasm Transplantation; D010879:Piperazines / Q000627:therapeutic use*; D010885:Pipobroman / Q000627:therapeutic use; D012334:RNA, Neoplasm / Q000096:biosynthesis; D013451:Sulfonic Acids / Q000627:therapeutic use; D013936:Thymidine / Q000378:metabolism; D014238:Trichloroacetic Acid; D014316:Tritium; D014529:Uridine / Q000378:metabolism
D000477:Alkylating Agents; D002247:Carbon Isotopes; D004273:DNA, Neoplasm; D009363:Neoplasm Proteins; D010879:Piperazines; D012334:RNA, Neoplasm; D013451:Sulfonic Acids; D014316:Tritium; D014238:Trichloroacetic Acid; D010885:Pipobroman; D007930:Leucine; D013936:Thymidine; D014529:Uridine